Malathion Patent Expiration

Malathion is Used for treating head lice and their eggs on the scalp hair. It was first introduced by Taro Pharmaceutical Industries Ltd in its drug Ovide on Aug 2, 1982. 3 different companies have introduced drugs containing Malathion.


Malathion Patents

Given below is the list of patents protecting Malathion, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Ovide US7560445 Process for preparing malathion for pharmaceutical use Feb 01, 2027 Taro
Ovide US7977324 Process for preparing malathion for pharmaceutical use Aug 14, 2026 Taro



Malathion's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Malathion Generic API Manufacturers

Several generic applications have been filed for Malathion. The first generic version for Malathion was by Norvium Bioscience Llc and was approved on Mar 6, 2009. And the latest generic version is by Suven Pharmaceuticals Ltd and was approved on May 23, 2012.

Given below is the list of companies who have filed for Malathion generic, along with the locations of their manufacturing plants worldwide.


1. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 1 generic for Malathion. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5%

lotion Discontinued TOPICAL N/A Mar 6, 2009





2. SUVEN PHARMS

Suven Pharmaceuticals Ltd has filed for 1 generic for Malathion. Given below are the details of the strengths of this generic introduced by Suven Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5%

(reference standard)

lotion Prescription TOPICAL N/A May 23, 2012